These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 12234020

  • 1. Pharmaceutical industry research and cost savings in community-acquired pneumonia.
    Kessler LA, Waterer GW, Barca R, Wunderink RG.
    Am J Manag Care; 2002 Sep; 8(9):798-800. PubMed ID: 12234020
    [Abstract] [Full Text] [Related]

  • 2. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M, Schein J, Mody S, Grant R, Benson C, Olson W.
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [Abstract] [Full Text] [Related]

  • 3. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
    Signorovitch JE, Sheng Duh M, Sengupta A, Gu A, Grant R, Raut M, Mody SH, Schein J, Fisher AC, Ng D.
    Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
    [Abstract] [Full Text] [Related]

  • 4. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [Abstract] [Full Text] [Related]

  • 5. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [Abstract] [Full Text] [Related]

  • 6. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
    Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ.
    Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK, Nopmaneejumruslers C, Chan CK.
    Am J Med; 2004 Mar 15; 116(6):385-93. PubMed ID: 15006587
    [Abstract] [Full Text] [Related]

  • 8. Community acquired pneumonia and direct hospital cost.
    Doruk S, Tertemiz KC, Kömüs N, Uçan ES, Kilinç O, Sevinç C.
    Tuberk Toraks; 2009 Mar 15; 57(1):48-55. PubMed ID: 19533437
    [Abstract] [Full Text] [Related]

  • 9. Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.
    Murcia JM, González-Comeche J, Marín A, Barberán J, Granizo JJ, Aguilar L, González-Moreno J, González-Pina B, López-Dupla M, Irurzun J, SCAPE Study Group.
    Clin Microbiol Infect; 2009 Nov 15; 15(11):1046-50. PubMed ID: 19548926
    [Abstract] [Full Text] [Related]

  • 10. Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.
    Cortoos PJ, Gilissen C, Laekeman G, Peetermans WE, Leenaers H, Vandorpe L, Simoens S.
    Scand J Infect Dis; 2013 Mar 15; 45(3):219-26. PubMed ID: 23113827
    [Abstract] [Full Text] [Related]

  • 11. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menéndez R, Lopardo G, Torres A, Rossi P, Ramirez JA, Community-Acquired Pneumonia Organization (CAPO) Investigators.
    Arch Intern Med; 2009 Sep 14; 169(16):1515-24. PubMed ID: 19752410
    [Abstract] [Full Text] [Related]

  • 12. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC, Ioachimescu AG, Iannini PB.
    Int J Antimicrob Agents; 2004 Nov 14; 24(5):485-90. PubMed ID: 15519482
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
    Rosenthal VD, Guzman S, Migone O, Safdar N.
    Am J Infect Control; 2005 Apr 14; 33(3):157-61. PubMed ID: 15798670
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
    Lavoie F, Blais L, Castilloux AM, Scalera A, LeLorier J.
    Can J Clin Pharmacol; 2005 Apr 14; 12(2):e212-7. PubMed ID: 15998960
    [Abstract] [Full Text] [Related]

  • 18. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG.
    Arch Intern Med; 2004 Mar 22; 164(6):637-44. PubMed ID: 15037492
    [Abstract] [Full Text] [Related]

  • 19. Community-acquired pneumonia in children: quantifying the burden on patients and their families including decrease in quality of life.
    Shoham Y, Dagan R, Givon-Lavi N, Liss Z, Shagan T, Zamir O, Greenberg D.
    Pediatrics; 2005 May 22; 115(5):1213-9. PubMed ID: 15867027
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.